Roberto Pili

4PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Multiphysics flows (incl. multiphase and reacting flows)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 13, 2026
MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer.

Surendra Gulla, Tej Sharma, Ephraim Gardner

|Aug 08, 2025
Caloric Restriction Enhances the Efficacy of Antiandrogen Therapy in Prostate Cancer by Inhibiting Androgen Receptor Translation.

Ricardo A Cordova, May Elbanna, Christopher Rupert

|Mar 27, 2025
A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma.

Roberto Pili, David I Quinn, Nabil Adra

|Jan 24, 2024
TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma.

Nur P Damayanti, Ricardo A Cordova, Christopher Rupert

Pageof 1

Frequent Collaborators

2 joint publications

Ricardo A Cordova

2 joint publications

Christopher Rupert

2 joint publications

Li Shen

2 joint publications

Sabrina Orsi